TransCode Therapeutics: And Exhibit 10.1. For Convenience, The Company Has Repeated The Full Text Of Item 1.01 Of The Original Form 8k Below With Corrected Information Included. In Addition, The Corrected Version Of The Investment Agreement (as Defined Below) Is Filed As Exhibit 10.1 Hereto And Supersedes And Replaces In Its Entirety Exhibit 10.1 To The Original Form 8k. Except As Stated In This Explanatory Note, This Amendment Does Not Otherwise Change Or Update The Disclosure Set Forth In The Original Form 8k, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  TransCode Therapeutics Inc
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***